Facts you should know about superior vena cava syndrome The most common cause of superior vena cava syndrome is cancer. Superior vena cava syndrome is most often caused by compression of the vein (the superior vena cava), that returns blood from the upper body back to the right atrium of the heart by the tumor. …
Read More »cancer
Clariscan (gadoterate meglumine): MRI Contrast Dye Side Effects & Dosage
What is Clariscan (gadoterate meglumine), and how is it used? Clariscan (gadoterate meglumine) is a prescription medicine called a gadolinium-based contrast agent (GBCA). Clariscan, like other GBCAs, is injected into your vein and used with a magnetic resonance imaging (MRI) scanner. An MRI exam with a GBCA, including Clariscan, helps your doctor to see problems better than an MRI exam …
Read More »Small Cell Lung Cancer vs. Non-Small Cell Lung Cancer Stages & Survival Rate
What is non-small cell lung cancer (NSCLC)? Readers Comments 2 Share Your Story Risk factors for lung cancer include smoking, exposure to air pollution, and genetics. Non-small cell lung cancer (NSCLC) is composed of three types of cancers that originate from lung tissue. The three types are known as adenocarcinomas, squamous cell carcinomas, and large cell carcinomas. Adenocarcinomas are slow-growing cancers that …
Read More »Mantle Cell Lymphoma (MCL): Treatment, Symptoms & Survival Rate
Mantle cell lymphoma (MCL) facts Readers Comments 6 Share Your Story MCL is an aggressive B-cell type of non-Hodgkin's lymphoma. NHL occurs when the body produces too many abnormal lymphocytes. Mantle cell lymphoma (MCL) is a relatively rare cancer of the lymphoid cells that arise from the outer rim or mantle lymphoid follicle. The cause of MCL is unknown, although …
Read More »Six Early Signs of Lung Cancer: How to Test, Risks & Prevention
What are the early signs of lung cancer? Six early signs of lung cancer include A new cough that persists for several weeks and goes on worsening, persistent shortness of breath, chest pain, and more. Lung cancer is the third most common cancer in the United States. It may not show its signs and symptoms in its early stages. Signs …
Read More »Lynparza (olaparib) Cancer Medication: Side Effects & Dosage
What is Lynparza, and how does it work? Lynparza is a prescription medicine used to treat adults who have: advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer with a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene. Lynparza is used alone as maintenance treatment after the cancer has responded to your first treatment with platinum-based …
Read More »Erbitux (cetuximab) for Colorectal Cancer: Side Effects & Warnings
What is Erbitux, and how does it work? Erbitux (cetuximab), in combination with radiation therapy, is a monoclonal antibody indicated for the initial treatment of locally or regionally advanced head and neck cancer of a specific type (squamous cell carcinoma). Used alone, Erbitux is also approved to treat patients with head and neck cancers that have returned in the same …
Read More »Lenvima (lenvatinib) Cancer Medication: Side Effects & Dosage
What is Lenvima, and how does it work? Lenvima is a prescription medicine that is used to treat certain kinds of cancer. Lenvima is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing. Lenvima is used along with another medicine called everolimus to …
Read More »Libtayo (cemiplimab-rwlc) for Skin Cancer: Side Effects & Dosage
What is Libtayo, and how does it work? Libtayo is a prescription medicine used to treat people with a type of skin cancer called cutaneous squamous cell carcinoma (CSCC) that has spread or cannot be cured by surgery or radiation. It is not known if Libtayo is safe and effective in children. What are the side effects of Libtayo? The …
Read More »Imfinzi (durvalumab) for Cancer: Side Effects & Dosage
What is Imfinzi, and how does it work? Imfinzi (durvalumab) is a programmed death-ligand 1 (PD-L1) blocking antibody indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy; or who have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy. It is also used …
Read More »